Result of Clinical Study

RNS Number : 1302F

Tristel PLC

12 June 2012

 



TRISTEL plc

Results of Clinical Study

Tristel plc ("Tristel"), the manufacturer of infection prevention, contamination control and hygiene products, announces that the results of an "Evaluation of disinfection of flexible nasendoscopes using Tristel wipes: a prospective single blind study", have been published in the Annals of the Royal College of Surgeons of England (Ann R Coll Surg Engi 2012: 94: 185-188).

The study, undertaken by the otorhinolaryngology (Ear Nose and Throat  or ENT) department at Northwick Park Hospital, North West London, showed the "in-use" efficacy of Tristel wipes in cleaning nasendoscopes of bacteria, fungi and mycobacteria to be 100%.

The Tristel wipes system is a unique, patented decontamination method for small flexible endoscopes and ultrasound probes.  It comprises a pre-clean wipe to remove surface soiling, a sporicidal wipe that kills harmful organisms within 30 seconds, and a rinse wipe.

Tristel CEO, Paul Swinney, commented: "The Northwick Park Hospital study adds to the body of scientific evidence demonstrating the superiority of the wipes system over other, longer established methods.  The wipes system for ENT is becoming established as the universal "gold standard" for nasendoscope decontamination in countries where it has been approved for use.  These include the UK, Germany, Italy, Spain, Australia and Hong Kong.  We anticipate that the wipes system will be approved by the Chinese authorities later this year."

For further information please contact:

Tristel plc	Tel: [phone]
Paul Swinney, Chief Executive Officer
Liz Dixon, Finance Director
Walbrook PR Ltd	Tel: [phone]
Fiona Henson	Mob: [phone] or [e-mail]
Paul Cornelius	Mob: [phone] or [e-mail]
finnCap	Tel: [phone]
Geoff Nash (Corporate Finance)
Charlotte Stranner (Corporate Finance)
Simon Starr (Corporate Broking)

 

END

 

 

NRAEFLFFLQFXBBE